Gallant Shark Tank Update
Stem cell banking for pets
What Happened to Gallant After Shark Tank
Is Gallant still in business? Yes — still in business and thriving.
$5.9M
reported annual revenue
- Deal with Lori Greiner and Anne Wojcicki did not close
- $5M annual revenue as of April 2023
- $15M Series A funding round in January 2024
- Pursuing FDA approval for stem cell therapies, expected 2025
- Valued at $20M as of July 2024
Last verified Apr 5, 2026. Web-confirmed sources.
Get updates on Gallant
The Gallant Shark Tank Pitch
Aaron Hirschhorn pitched Gallant on Shark Tank Season 11, Episode 8, which aired Sunday, November 17, 2019, asking for $500,000 for 2% of the company — a $25M valuation.
Lori Greiner and Anne Wojcicki teamed up and agreed to invest $500,000 for 5% equity, valuing the company at $10M. The deal fell through after the show. Deal with Lori Greiner and Anne Wojcicki never closed; company raised Series A independently.
Watch the Pitch
Pitch Details
- Aired
- S11E8Nov 17, 2019
- Ask
- $500,000for 2%
- Ask Valuation
- $25M
Deal Terms
Terms agreed on air. The deal did not close.
- Amount
- $500,000
- Equity
- 5%
- Valuation
- $10M
Lori Greiner
Anne Wojcicki